Veradigm Return on Investment 2011-2022 | MDRX
Current and historical return on investment (ROI) values for Veradigm (MDRX) over the last 10 years.
| Veradigm ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2022-12-31 | $-0.03B | $1.22B | -1.82% |
| 2022-09-30 | $0.06B | $1.38B | 3.93% |
| 2022-06-30 | $0.05B | $1.40B | 3.26% |
| 2022-03-31 | $0.08B | $1.73B | 4.31% |
| 2021-12-31 | $0.08B | $1.71B | 4.30% |
| 2021-09-30 | $0.11B | $1.79B | 6.26% |
| 2021-06-30 | $0.09B | $1.82B | 4.40% |
| 2021-03-31 | $0.04B | $1.85B | 2.20% |
| 2020-12-31 | $0.01B | $1.83B | 0.41% |
| 2020-09-30 | $-0.17B | $2.23B | -8.76% |
| 2020-06-30 | $-0.16B | $1.91B | -8.48% |
| 2020-03-31 | $-0.13B | $1.92B | -6.67% |
| 2019-12-31 | $-0.10B | $1.84B | -4.93% |
| 2019-09-30 | $-0.09B | $1.84B | -4.32% |
| 2019-06-30 | $-0.09B | $2.14B | -3.96% |
| 2019-03-31 | $-0.16B | $2.22B | -6.29% |
| 2018-12-31 | $-0.17B | $2.23B | -6.32% |
| 2018-09-30 | $-0.11B | $2.91B | -4.25% |
| 2018-06-30 | $-0.09B | $2.76B | -3.43% |
| 2018-03-31 | $-0.01B | $2.81B | -0.24% |
| 2017-12-31 | $0.01B | $2.07B | 0.50% |
| 2017-09-30 | $0.08B | $2.53B | 3.06% |
| 2017-06-30 | $0.07B | $2.48B | 2.73% |
| 2017-03-31 | $0.07B | $2.49B | 2.64% |
| 2016-12-31 | $0.07B | $2.58B | 2.82% |
| 2016-09-30 | $0.07B | $2.58B | 3.12% |
| 2016-06-30 | $0.06B | $2.52B | 2.94% |
| 2016-03-31 | $0.05B | $1.98B | 2.48% |
| 2015-12-31 | $0.03B | $2.03B | 1.62% |
| 2015-09-30 | $0.01B | $2.04B | 0.52% |
| 2015-06-30 | $-0.02B | $2.02B | -0.96% |
| 2015-03-31 | $-0.03B | $1.82B | -1.80% |
| 2014-12-31 | $-0.04B | $1.82B | -2.13% |
| 2014-09-30 | $-0.07B | $1.85B | -3.69% |
| 2014-06-30 | $-0.09B | $1.84B | -4.97% |
| 2014-03-31 | $-0.11B | $1.84B | -5.95% |
| 2013-12-31 | $-0.13B | $1.86B | -6.85% |
| 2013-09-30 | $-0.13B | $1.86B | -7.00% |
| 2013-06-30 | $-0.07B | $1.90B | -4.21% |
| 2013-03-31 | $-0.03B | $1.79B | -1.64% |
| 2012-12-31 | $0.01B | $1.65B | 0.76% |
| 2012-09-30 | $0.09B | $1.69B | 4.93% |
| 2012-06-30 | $0.11B | $1.70B | 6.29% |
| 2012-03-31 | $0.13B | $1.79B | 6.99% |
| 2011-12-31 | $0.14B | $1.80B | 7.55% |
| 2011-09-30 | $0.10B | $1.78B | 5.51% |
| 2011-06-30 | $0.07B | $1.79B | 3.54% |
| 2011-03-31 | $0.05B | $1.84B | 3.88% |
| 2010-09-30 | $0.05B | $1.88B | 11.09% |
| 2010-06-30 | $0.09B | 42.45% | |
| 2010-03-31 | $0.09B | 15.27% | |
| 2010-02-28 | $0.08B | $0.80B | 13.59% |
| 2009-09-30 | $0.07B | 11.51% | |
| 2009-08-31 | $0.04B | $0.78B | 4.50% |
| 2009-02-28 | $0.03B | $0.79B | 5.06% |
| 2008-11-30 | $0.01B | $0.78B | 1.83% |
| 2008-08-31 | $0.02B | 5.60% | |
| 2008-06-30 | $0.02B | $0.48B | 8.22% |
| 2008-03-31 | $0.03B | $0.48B | 13.00% |
| 2008-02-29 | $0.04B | 16.55% | |
| 2007-12-31 | $0.03B | $0.48B | 8.52% |
| 2007-11-30 | $0.01B | 2.86% | |
| 2007-09-30 | $0.00B | $0.42B | 1.28% |
| 2007-06-30 | $0.00B | $0.42B | 1.30% |
| 2007-05-31 | $0.00B | 1.00% | |
| 2007-03-31 | $0.03B | $0.41B | 6.31% |
| 2006-12-31 | $0.02B | $0.40B | 5.15% |
| 2006-09-30 | $0.02B | $0.39B | 4.80% |
| 2006-06-30 | $0.01B | $0.38B | 4.66% |
| 2006-03-31 | $0.01B | $0.38B | 4.42% |
| 2005-12-31 | $0.01B | $0.18B | 5.19% |
| 2005-09-30 | $0.01B | $0.18B | 4.75% |
| 2005-06-30 | $0.01B | $0.17B | 3.66% |
| 2005-03-31 | $0.01B | $0.17B | 4.12% |
| 2004-12-31 | $0.00B | $0.16B | 5.00% |
| 2004-09-30 | $0.00B | $0.16B | 5.03% |
| 2004-06-30 | $0.00B | 0.00% | |
| 2004-03-31 | $0.00B | 0.00% | |
| 2003-12-31 | $-0.01B | 0.00% | |
| 2003-09-30 | $-0.01B | 0.00% | |
| 2003-06-30 | $-0.01B | 0.00% | |
| 2003-03-31 | $-0.01B | 0.00% | |
| 2002-12-31 | $-0.02B | 0.00% | |
| 2002-09-30 | $-0.03B | 0.00% | |
| 2002-06-30 | $-0.42B | 0.00% | |
| 2002-03-31 | $-0.45B | 0.00% | |
| 2001-12-31 | $-0.47B | 0.00% | |
| 2001-09-30 | $-0.48B | 0.00% | |
| 2001-06-30 | $-0.10B | 0.00% | |
| 2001-03-31 | $-0.10B | 0.00% | |
| 2000-12-31 | $-0.07B | 0.00% | |
| 2000-09-30 | $-0.06B | -340.30% | |
| 2000-06-30 | $-0.05B | -129.50% | |
| 2000-03-31 | $-0.02B | -58.33% | |
| 1999-12-31 | $-0.02B | $0.07B | -42.38% |
| 1999-06-30 | $0.00B | $0.01B | 22.22% |
| 1999-03-31 | $0.01B | $0.01B | 307.69% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.523B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.330B | 58.97 |
| Tempus AI (TEM) | United States | $12.432B | 0.00 |
| Doximity (DOCS) | United States | $10.168B | 42.08 |
| Hims & Hers Health (HIMS) | United States | $9.340B | 75.98 |
| IRhythm Technologies (IRTC) | United States | $5.625B | 0.00 |
| Hinge Health (HNGE) | United States | $3.490B | 0.00 |
| Privia Health (PRVA) | United States | $2.882B | 180.23 |
| Heartflow (HTFL) | United States | $2.715B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.377B | 39.32 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Enovis (ENOV) | United States | $1.605B | 8.43 |
| Omnicell (OMCL) | United States | $1.601B | 32.73 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Phreesia (PHR) | United States | $1.319B | 0.00 |
| Schrodinger (SDGR) | United States | $1.309B | 0.00 |
| Claritev (CTEV) | United States | $1.141B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Evolent Health (EVH) | United States | $0.583B | 0.00 |
| Talkspace (TALK) | United States | $0.565B | 113.67 |
| Standard BioTools (LAB) | United States | $0.435B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.396B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.295B | 0.00 |
| TruBridge (TBRG) | United States | $0.292B | 13.39 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.180B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.167B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.06 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| Pulmonx (LUNG) | United States | $0.078B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.068B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.026B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |